TAAR1 and schizophrenia: Although evidence exists for the therapeutic effects of 5-HT1A agonists in depression and anxiety-related disorders [47], the potential for efficacy of 5-HT1A agonists in schizophrenia, particularly in combination with TAAR1 agonism, remains to be explored.